Levels of Selected Aqueous Humor Mediators (IL-10, IL-17, CCL2, VEGF, FasL) in Diabetic Cataract

References

• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053
   PubMed Web of Science ®Google Scholar
• Benson WE. Cataract surgery and diabetic retinopathy. Curr Opin Ophthalmol. 1992;3:396–400
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology. 1985;92:1191–1196
   PubMed Web of Science ®Google Scholar
• Nielsen NV, Vinding T. The prevalence of cataract in insulin-dependent and non-insulin-dependent-diabetes mellitus. Acta Ophthalmol (Copenh). 1984;62:595–602
   PubMed Web of Science ®Google Scholar
• Hamilton AMP. Epidemiology of diabetic retinopathy. In: Hamilton AMP, Ulbig MW, Polkinghorne P, eds. Management of Diabetic Retinopathy. London: BMJ; 1996:1–15
   Google Scholar
• Obrosova IG, Minchenko AG, Vasupuram R, et al. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes. 2003;52:864–871
   PubMed Web of Science ®Google Scholar
• Pollreisz A, Schmidt-Erfurth U. Diabetic cataract—pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:1--8
   Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Noma H, et al. Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy. J Cataract Refract Surg. 2002;28:1355–1363
   PubMed Web of Science ®Google Scholar
• Chu L, Wang B, Xu B, et al. Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. Mol Vis. 2013;19:2418–2425
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Noma H, et al. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol. 2002;133:70–77
   PubMed Web of Science ®Google Scholar
• Gverovic Antunica A, Karaman K, Znaor L, et al. IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients. Graefes Arch Clin Exp Ophthalmol. 2012;250:815–821
   PubMed Web of Science ®Google Scholar
• Jonas JB, Jonas RA, Neumaier M, et al. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina. 2012;32:2150–2157
   PubMed Web of Science ®Google Scholar
• Cheung CM, Vania M, Ang M, et al. Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol Vis. 2012;18:830–837
   PubMed Web of Science ®Google Scholar
• Dong N, Xu B, Wang B, et al. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis. 2013;19:1734–1746
   PubMed Web of Science ®Google Scholar
• Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 41:3158–3164
   Google Scholar
• Funatsu H, Yamashita H, Sakata K, et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology. 2005;112:806–816
   PubMed Web of Science ®Google Scholar
• Demircan N, Safran BG, Soylu M, et al. Determination of vitreous interleukin-1 (IL–1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond). 2006;20:1366–1369
   PubMed Web of Science ®Google Scholar
• Kang MH, Kim MK, Lee HJ, et al. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci. 2011;26:938–944
   PubMed Web of Science ®Google Scholar
• Roychoudhury J, Herndon JM, Yin J, et al. Targeting immune privilege to prevent pathogenic neovascularization. Invest Ophthalmol Vis Sci. 2010;51:3560–3566
   PubMed Web of Science ®Google Scholar
• Altintas AG, Yilmaz E, Anayol MA, et al. Comparison of corneal edema caused by cataract surgery with different phaco times in diabetic and non-diabetic patients. Ann Ophthalmol (Skokie). 2006;38:61–65
   PubMed Web of Science ®Google Scholar
• Amon M, Menapace R, Scheidel W. Results of corneal pachymetry after small-incision hydrogel lens implantation and scleral-step incision poly(methyl methacrylate) lens implantation following phacoemulsification. J Cataract Refract Surg. 1991;17:466–470
   PubMed Web of Science ®Google Scholar
• Stefek M, Karasu C. Eye lens in aging and diabetes: effect of quercetin. Rejuvenation Res. 2011;14:525–534
   PubMed Web of Science ®Google Scholar
• Panchapakesan J, Mitchell P, Tumuluri K, et al. Five year incidence of cataract surgery: the Blue Mountains Eye Study. Br J Ophthalmol. 2003;87:168–172
   PubMed Web of Science ®Google Scholar
• Wong WL, Li X, Li J, et al. Cataract conversion assessment using lens opacity classification system III and Wisconsin cataract grading system. Invest Ophthalmol Vis Sci. 2013;54:280–287
   PubMed Web of Science ®Google Scholar
• Mitchell P, Cumming RG, Attebo K, et al. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology. 1997;104:581–588
   PubMed Web of Science ®Google Scholar
• Crandall AS, Zabriskie NA, Patel BC, et al. A comparison of patient comfort during cataract surgery with topical anesthesia versus topical anesthesia and intracameral lidocaine. Ophthalmology. 1999;106:60–66
   PubMed Web of Science ®Google Scholar
• Storey JD. A direct approach to false discovery rates. J R Stat Soc. 2002;64:479–498
   Google Scholar
• Oh IK, Kim SW, Oh J, et al. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res. 2010;35:1116–1127
   PubMed Web of Science ®Google Scholar
• Schoenberger SD, Kim SJ, Sheng J, et al. Increased prostaglandin e2 (pge2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines. Invest Ophthalmol Vis Sci. 2012;53:5906–5911
   PubMed Web of Science ®Google Scholar
• Tashimo A, Mitamura Y, Nagai S, et al. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy. Diabet Med. 2004;21:1292–1297
   PubMed Web of Science ®Google Scholar
• Mine S, Okada Y, Tanikawa T, et al. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem Biophys Res Commun. 2006;344:780–785
   PubMed Web of Science ®Google Scholar
• Okamura N, Ito Y, Shibata MA, et al. Fas-mediated apoptosis in human lens epithelial cells of cataracts associated with diabetic retinopathy. Med Electron Microsc. 2002;35:234–241
   PubMedGoogle Scholar
• Kim B, Kim SY, Chung SK. Changes in apoptosis factors in lens epithelial cells of cataract patients with diabetes mellitus. J Cataract Refract Surg. 2012;38:1376–1381
   PubMed Web of Science ®Google Scholar
• Stein-Streilein J. Immune regulation and the eye. Trends Immunol. 2008;29:548–554
   PubMed Web of Science ®Google Scholar
• Griffith TS, Yu X, Herndon JM, et al. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5:7–16
   PubMed Web of Science ®Google Scholar
• Kovacic N, Grcevic D, Katavic V, et al. Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets. 2010;14:1121–1134
   PubMed Web of Science ®Google Scholar
• Nolan A, Weiden MD, Thurston G, et al. Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis. Inflammation. 2004;28:271–278
   PubMed Web of Science ®Google Scholar
• Daniele G, Guardado Mendoza R, Winnier D, et al. The inflammatory status score including IL–6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol. 2014;51:123–131
   PubMed Web of Science ®Google Scholar
• Almeida DR, Johnson D, Hollands H, et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg. 2008;34:64–69
   PubMed Web of Science ®Google Scholar
• Almeida DR, Khan Z, Xing L, et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. J Cataract Refract Surg. 2012;38:1537–1543
   PubMed Web of Science ®Google Scholar